| # | Drug | Count |
|---|---|---|
| 0 | CALCIUM | 2 |
| 1 | CAPECITABINE | 2 |
| 2 | CELECOXIB | 2 |
| 3 | DABIGATRAN ETEXILATE | 2 |
| 4 | DABIGATRAN ETEXILATE MESYLATE | 2 |
| 5 | FENTANYL | 2 |
| 6 | FLUTICASONE PROPIONATE AND SALMETEROL | 2 |
| 7 | GABAPENTIN | 2 |
| 8 | INSULIN | 2 |
| 9 | LAPATINIB | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEMIGATINIB | 1 | 0.0012 |
| 1 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | 1 | 0.0004 |
| 2 | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | 1 | 0.0004 |
| 3 | MITOMYCIN | 1 | 0.0003 |
| 4 | LAPATINIB | 2 | 0.0001 |
| 5 | OXYCODONE AND ACETAMINOPHEN | 2 | 0.0001 |
| 6 | SIROLIMUS | 1 | 0.0001 |
| 7 | EVEROLIMUS TABLETS | 1 | 0.0001 |
| 8 | NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0000 |
| 9 | NIRAPARIB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 3 |
| 1 | Kinase Inhibitor [EPC] | 3 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 3 |
| 3 | Benzodiazepine [EPC] | 2 |
| 4 | Calcium [EPC] | 2 |
| 5 | Insulin Analog [EPC] | 2 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| 7 | Opioid Agonist [EPC] | 2 |
| 8 | Prostacycline Vasodilator [EPC] | 2 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 2 | 0.0000 |
| 1 | Calcium [EPC] | 2 | 0.0000 |
| 2 | Non-Standardized Chemical Allergen [EPC] | 1 | 0.0000 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Opioid Agonist [EPC] | 2 | 0.0000 |
| 8 | Selective T Cell Costimulation Modulator [EPC] | 1 | 0.0000 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 1 | 0.0000 |